Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

por Tay-Teo, Kiu, Ilbawi, André, Hill, Suzanne R.
Publicado 2019

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

por Iyengar, Swathi, Tay-Teo, Kiu, Vogler, Sabine, Beyer, Peter, Wiktor, Stefan, de Joncheere, Kees, Hill, Suzanne
Publicado 2016

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

por Trapani, Dario, Tay-Teo, Kiu, Tesch, Megan E., Roitberg, Felipe, Sengar, Manju, Altuna, Sara C., Hassett, Michael J., Genazzani, Armando A., Kesselheim, Aaron S., Curigliano, Giuseppe
Publicado 2022